| Humanized mice for studies of HIV-1 persistence and elimination C Zhang, LA Zaman, LY Poluektova, S Gorantla, HE Gendelman, ... Pathogens 12 (7), 879, 2023 | 11 | 2023 |
| HIV-1 and methamphetamine alter galectins-1,-3, and-9 in human monocyte-derived macrophages K Grabowska, K Macur, S Zieschang, L Zaman, N Haverland, A Schissel, ... Journal of neurovirology 28 (1), 99-112, 2022 | 5 | 2022 |
| Polymer Delivery Systems for Long-Acting Antiretroviral Drugs MU Nayan, S Panja, A Sultana, LA Zaman, LK Vora, B Sillman, ... Pharmaceutics 16 (2), 183, 2024 | 4 | 2024 |
| Delivery of gene editing therapeutics BD Kevadiya, F Islam, P Deol, LA Zaman, DA Mosselhy, ... Nanomedicine: Nanotechnology, Biology and Medicine, 102711, 2023 | 3 | 2023 |
| The CXCR1 Axis: A Putative Therapeutic Cancer Stem Cell-Like Marker in Pancreatic Ductal Adenocarcinoma E Thomas, C Molczyk, P Goel, M Powers, LA Zaman, E Ehrhorn, S Cohen, ... | 1 | 2021 |
| CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities HE Gendelman, M Patel, S Panja, LA Zaman, P Yeapuri, S Bhattarai, ... | | 2024 |
| CXCR1: A novel therapeutic avenue for CSC-like phenotypes in pancreatic ductal adenocarcinoma C Molczyk, E Thomas, L Zaman, P Goel, RK Singh Cancer Research 82 (12_Supplement), 894-894, 2022 | | 2022 |
